Skip to main content

TNBC

1. Triple negative breast cancer (TNBC) is a subtype of breast cancer that lacks three specific receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This means that TNBC does not respond to hormonal therapies or targeted therapies that target these receptors.


2. TNBC accounts for approximately 10-20% of all breast cancer cases. It is more commonly diagnosed in younger women, African American women, and women with a BRCA1 gene mutation.


3. TNBC tends to be more aggressive and has a higher risk of recurrence compared to other types of breast cancer. It may also have a higher likelihood of spreading to other organs, such as the lungs or brain.


4. Due to the lack of targeted therapies, chemotherapy is the primary treatment option for TNBC. This can include a combination of drugs, such as anthracyclines and taxanes.


5. Research is ongoing to identify potential targeted therapies for TNBC. Some promising areas of study include immunotherapy, PARP inhibitors, and drugs that target specific molecular pathways involved in TNBC.


6. It is important for individuals with TNBC to work closely with their healthcare team to develop a personalized treatment plan. This may include regular follow-up appointments, imaging tests, and discussions about potential clinical trials or new treatment options.C

Comments

Post a Comment

Popular posts from this blog

Firefly lane

  My diagnosis  shattered the preconceived notions around friendship, loyalty, and support. I recall my journey and reflect on the impact of having a limited support system during one of the toughest battles
3 comments
Read more

Cancer and Black History

Dr. LaSalle D. Leffall Jr. was an African American surgeon and cancer researcher who made significant contributions to the field of oncology. Born in 1930 in Tallahassee, Florida, Dr. Leffall faced racial discrimination and segregation throughout his early life. Despite these challenges, he excelled academically and went on to become the first African American to graduate from the University of Florida College of Medicine in 1952. Dr. Leffall's interest in cancer research and treatment led him to pursue a career in surgical oncology. He became a pioneer in the field, specializing in the treatment of colorectal cancer and other malignancies. Throughout his career, he held various leadership positions, including serving as the President of the American Cancer Society and the American College of Surgeons. In addition to his clinical work, Dr. Leffall was a passionate advocate for cancer prevention and education, particularly within the African American community. He recognized the dis
Post a Comment
Read more